Influence
August 1, 2025

Symptom Burden in Adolescents and Young Adults With Cancer

Kurt Kroenke, MD

Published in the JAMA Network Open. Here is a link to the article.

Regenstrief Institute authors: Kurt Kroenke, M.D.

This study looked at how symptoms affect adolescents and young adults ages 18 to 39 with cancer compared to older adults. Using data from the E2C2 trial, researchers analyzed six symptoms patients reported: trouble sleeping, pain, limited physical function, anxiety, depression, and fatigue. Younger adults with cancer were more often female, single, employed, and college educated, and more likely to live in cities. They were also more likely to have sarcoma or brain cancers and less likely to have cancer that had spread. The goal was to understand which factors are linked to more severe symptoms so care teams can better support younger cancer patients.

Authors: 

Michael H Storandt 1Zhaohui Jin 1Kathryn J Ruddy 1Deirdre R Pachman 1Oudom Kour 1Veronica Grzegorczyk 1Kurt Kroenke 2Joan M Griffin 1Jessica D Austin 3Sandra A Mitchell 4Ashley Wilder Smith 4Shawna Ehlers 1Linda L Chlan 1Ewan K Cobran 1Jacob R Greenmyer 1Wendy A Allen-Rhoades 1Qian Shi 1Andrea L Cheville 1

Affiliations

1Mayo Clinic, Rochester, Minnesota.

2Indiana University School of Medicine, Indianapolis.

3Mayo Clinic, Phoenix, Arizona.

4National Cancer Institute, Bethesda, Maryland.

Related News

Regenstrief Institute and Suki partner to evaluate ambient AI in healthcare

Organizations share a commitment to understanding how ambient AI technologies impact clinicians, patients and healthcare delivery  Regenstrief Institute and Suki, a

Dr. Peter J. Embi

Regenstrief’s legacy with the National Library of Medicine continues

Peter J. Embí, M.D., M.S., former president and CEO of the Regenstrief Institute, has been appointed director of the

image showing two people connecting through a kidney

Regenstrief Institute awarded KidneyX prize to advance living kidney donation

LIVINGkidney digital tool recognized in national HHS competition focused on reducing barriers for living kidney donors and transplant patients  Regenstrief

LOINC® version 2.83 enhances global health data exchange through new terminology and implementation improvements

Release expands terminology for drug and toxicology testing, microbiology, public health reporting and allergy information Regenstrief Institute has released